Resistance Development: A Major Piece in the Jigsaw Puzzle of Tumor Size Modeling

Area of Science:

• Pharmacometrics
• Mathematical Oncology
• Drug Resistance Modeling

Background:

• Tumor size (TS) and tumor growth inhibition (TGI) models are crucial for predicting anticancer drug efficacy.
• Current models often lack sufficient emphasis on the development of drug resistance, a key factor impacting clinical outcomes.
• Integrating mechanistic insights into modeling can enhance the accuracy of predicting drug effects.

Purpose of the Study:

• To propose a general framework for developing semi-mechanistic mathematical models that incorporate drug resistance.
• To improve the prediction of anticancer drug effects by accounting for resistance development.
• To foster better data integration across different complexity levels for enhanced modeling.

Main Methods:

• Development of a general framework for semi-mechanistic TS/TGI models.
• Focus on incorporating mechanistic aspects of drug resistance.
• Consideration of data integration at various complexity levels.

Main Results:

• A proposed framework for advanced TS/TGI modeling.
• Enhanced potential for predicting anticancer drug effects.
• Foundation for future research integrating drug resistance.

Conclusions:

• Semi-mechanistic models need to prioritize drug resistance mechanisms for improved clinical outcome prediction.
• The proposed framework facilitates the development of more robust and predictive mathematical models for cancer therapy.
• Further research integrating resistance is essential for advancing pharmacometric approaches in oncology.